Clinical trial

A Trial of HR17031 Injection With Renal Insufficiency

NCT05292495

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-12

PhasePHASE1

Study timeline

Study start (actual)2022-10-12Date precision: day

Registry last updated2026-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Improved Glycemic Control in Patients With Type 2 Diabetesunresolved

Interventions

HR17031 injectionDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05292495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.